Iris Nederlof

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 854 citations

Tumor Immunology, Breast Oncology, Cancer Immunosurveillance +10

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

Dora Hammerl, John W.M. Martens, Mieke Timmermans et al. · Nature Communications · 2021 · 229 citations · Full text

Breast Oncology, Immunology, Immune Regulation +20

DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer

Yoni Schirris, Efstratios Gavves, Iris Nederlof et al. · Medical Image Analysis · 2022 · 121 citations · Full text

Image Analysis, Machine Learning, Data Science +15

Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer

Iris Nederlof, Davide De Bortoli, Yacine Barèche et al. · Breast Cancer Research · 2019 · 50 citations · Full text

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

Iris Nederlof, Olga I. Isaeva, Manon De Graaf et al. · Nature Medicine · 2024 · 44 citations · Full text